Avid Bioservices Inc (CDMO)

[jakedogman1]

Read Ronin's letter carefully. They say the current team should not be advancing the IP ball. The current team has zero credibility and the next step involves human trials. There is a big competition for patients among BP and PPHM has zero chance in getting access to the "good" patients (the ones that give you good readouts with data... wink wink). And even if they were to run trials, they have zero credibility no matter how good the results. In the meantime, other aspects/avenues for the IP sit on the shelf.

The current BOD amounts to a negative $1 bil in shareholder value. All imo.